Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis 6 November 2026
Long-term PERSEUS results confirm sustained benefit of daratumumab-based therapy in newly diagnosed multiple myeloma 6 November 2026
Daratumumab and isatuximab show comparable efficacy in newly diagnosed multiple myeloma 6 November 2026
High burden of germline variants of uncertain significance in advanced renal cell carcinoma: insights from an Indian cohort 5 November 2026
The evidence base of Clinical Practice Guidelines for cancer in China, the Hong Kong SAR and Taiwan 3 November 2026
Validation of the Spanish version of the shame and sigma scale for head and neck cancer survivors 3 November 2026